Image: Exscientia

Exscientia Appoints Georgy Egorov as CFO

Exscientia, a company in Artificial Intelligence (AI)-driven drug discovery, has announced the appointment of Mr Georgy Egorov as Chief Financial Officer (CFO).

He joins Exscientia from CompareEuropeGroup, where he was CFO and Board Member. Prior to that, he spent 20 years working in the financial industry, including senior roles at UBS as Managing Director, Head of EMEA Emerging Markets Equity Capital Markets and Goldman Sachs, where he was an Executive Director covering Equity and Debt Markets.

Andrew Hopkins, CEO of Exscientia, said: “We are delighted to welcome Georgy to the team at this exciting time for Exscientia. Georgy brings an impressive array of skills and experience, particularly in fund raising, corporate strategy and development. We believe that this will greatly support Exscientia’s ambitious growth plans as we pursue the industrialisation of our unique AI platform, development of our proprietary pipeline and advancement of existing and future partnered programmes.”